Booster Immunization Improves Memory B Cell Responses in Older Adults Unresponsive to Primary SARS-CoV-2 Immunization
Author:
Verheul Marije K.1, Nijhof Kim H.1, de Zeeuw-Brouwer Mary-lène1, Duijm Geraly1, ten Hulscher Hinke1, de Rond Lia1, Beckers Lisa1, Eggink Dirk2, van Tol Sophie2, Reimerink Johan2, Boer Mardi1, van Beek Josine1ORCID, Rots Nynke1, van Binnendijk Rob1, Buisman Anne-Marie1
Affiliation:
1. Centre for Immunology of Infectious Diseases and Vaccines, Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 MA Bilthoven, The Netherlands 2. Centre for Infectious Diseases Research, Diagnostics and Laboratory Surveillance, WHO COVID-19 Reference Laboratory, Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), 3721 MA Bilthoven, The Netherlands
Abstract
The generation of a specific long-term immune response to SARS-CoV-2 is considered important for protection against COVID-19 infection and disease. Memory B cells, responsible for the generation of antibody-producing plasmablasts upon a new antigen encounter, play an important role in this process. Therefore, the induction of memory B cell responses after primary and booster SARS-CoV-2 immunizations was investigated in the general population with an emphasis on older adults. Participants, 20–99 years of age, due to receive the mRNA-1273 or BNT162b2 SARS-CoV-2 vaccine were included in the current study. Specific memory B cells were determined by ex vivo ELISpot assays. In a subset of participants, antibody levels, avidity, and virus neutralization capacity were compared to memory B cell responses. Memory B cells specific for both Spike S1 and receptor-binding domain (RBD) were detected in the majority of participants following the primary immunization series. However, a proportion of predominantly older adults showed low frequencies of specific memory B cells. Booster vaccination resulted in a large increase in the frequencies of S1- and RBD-specific memory B cells also for those in which low memory B cell frequencies were detected after the primary series. These data show that booster immunization is important for the generation of a memory B cell response, as a subset of older adults shows a suboptimal response to the primary SARS-CoV-2 immunization series. It is anticipated that these memory B cells will play a significant role in the immune response following viral re-exposure.
Funder
Dutch Ministry of Health Welfare and Sports
Subject
Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology
Reference46 articles.
1. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: A statistical analysis;Barber;Lancet,2022 2. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: Results of a systematic review and meta-regression;Feikin;Lancet,2022 3. Perry, J., Osman, S., Wright, J., Richard-Greenblatt, M., Buchan, S.A., Sadarangani, M., and Bolotin, S. (2022). Does a humoral correlate of protection exist for SARS-CoV-2? A systematic review. PLoS ONE, 17. 4. Evidence for antibody as a protective correlate for COVID-19 vaccines;Earle;Vaccine,2021 5. Correlates of protection against SARS-CoV-2 in rhesus macaques;McMahan;Nature,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|